|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36
Cancers in 185 Countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gong L, Hu Y, He D, Zhu Y, Xiang L, Xiao
M, Bao Y, Liu X, Zeng Q, Liu J, et al: Ubiquitin ligase CHAF1B
induces cisplatin resistance in lung adenocarcinoma by promoting
NCOR2 degradation. Cancer Cell Int. 20:1942020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esai Selvan M, Zauderer MG, Rudin CM,
Jones S, Mukherjee S, Offit K, Onel K, Rennert G, Velculescu VE,
Lipkin SM, et al: Inherited rare, deleterious variants in ATM
increase lung adenocarcinoma risk. J Thorac Oncol. 15:1871–1879.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y, Zhang H, Fan L, Mou J, Yin Y, Peng
C, Chen Y, Lu H, Zhao L, Tao Z, et al: MiR-629-5p promotes the
invasion of lung adenocarcinoma via increasing both tumor cell
invasion and endothelial cell permeability. Oncogene. 39:3473–3488.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rose MC, Kostyanovskaya E and Huang RS:
Pharmacogenomics of cisplatin sensitivity in non-small cell lung
cancer. Genomics Proteomics Bioinformatics. 12:198–209. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bakir B, Chiarella AM, Pitarresi JR and
Rustgi AK: EMT, MET, plasticity, and tumor metastasis. Trends Cell
Biol. 30:764–776. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Piera-Velazquez S and Jimenez SA:
Endothelial to mesenchymal transition: Role in physiology and in
the pathogenesis of human diseases. Physiol Rev. 99:1281–1324.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao ZW, Liu C, Yang L, Chen HC, Yang LF,
Zhang HZ and Dong K: CD73 severed as a potential prognostic marker
and promote lung cancer cells migration via enhancing EMT
progression. Front Genet. 12:7282002021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu TT, Zhang T, Su F, Li YL, Shan L, Hou
XM and Wang RZ: ELK1 Promotes epithelial-mesenchymal transition and
the progression of lung adenocarcinoma by upregulating B7-H3. Oxid
Med Cell Longev. 2021:28055762021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Z, Liu J, Li Y, Wang H, Liang Z, Deng
X, Fu Q, Fang W and Xu P: VPS33B suppresses lung adenocarcinoma
metastasis and chemoresistance to cisplatin. Genes Dis. 8:307–319.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chua KN, Poon KL, Lim J, Sim WJ, Huang RY
and Thiery JP: Target cell movement in tumor and cardiovascular
diseases based on the epithelial-mesenchymal transition concept.
Adv Drug Deliv Rev. 63:558–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen T, You Y, Jiang H and Wang ZZ:
Epithelial-mesenchymal transition (EMT): A biological process in
the development, stem cell differentiation, and tumorigenesis. J
Cell Physiol. 232:3261–3272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Habib GM, Shi ZZ, Cuevas AA and Lieberman
MW: Identification of two additional members of the membrane-bound
dipeptidase family. FASEB J. 17:1313–1315. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kozak EM and Tate SS:
Glutathione-degrading enzymes of microvillus membranes. J Biol
Chem. 257:6322–6327. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Habib GM, Shi ZZ, Cuevas AA, Guo Q, Matzuk
MM and Lieberman MW: Leukotriene D4 and cystinyl-bis-glycine
metabolism in membrane-bound dipeptidase-deficient mice. Proc Natl
Acad Sci USA. 95:4859–63. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park SY, Lee SJ, Cho HJ, Kim TW, Kim JT,
Kim JW, Lee CH, Kim BY, Yeom YI, Lim JS, et al: Dehydropeptidase 1
promotes metastasis through regulation of E-cadherin expression in
colon cancer. Oncotarget. 7:9501–9512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayashi K, Longenecker KL, Koenig P,
Prashar A, Hampl J, Stoll V and Vivona S: Structure of human DPEP3
in complex with the SC-003 antibody Fab fragment reveals basis for
lack of dipeptidase activity. J Struct Biol. 211:1075122020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
von Mässenhausen A, Zamora Gonzalez N,
Maremonti F, Belavgeni A, Tonnus W, Meyer C, Beer K, Hannani MT,
Lau A, Peitzsch M, et al: Dexamethasone sensitizes to ferroptosis
by glucocorticoid receptor-induced dipeptidase-1 expression and
glutathione depletion. Sci Adv. 8:eabl89202022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang X, Yue Y and Xiong S: Dpep2 emerging
as a modulator of macrophage inflammation confers protection
against CVB3-induced viral myocarditis. Front Cell Infect
Microbiol. 9:572019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang G, Zhang J, Gong L, Wang X, Zhang B
and Liu D: Characterization of the fatty acid metabolism-related
genes in lung adenocarcinoma to guide clinical therapy. BMC Pulm
Med. 22:4862022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han T, Liu Y, Wu J, Bai Y, Zhou J, Hu C,
Zhang W, Guo J, Wang Q and Hu D: An immune indicator based on BTK
and DPEP2 identifies hot and cold tumors and clinical treatment
outcomes in lung adenocarcinoma. Sci Rep. 13:51532023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamilton E, O'Malley DM, O'Cearbhaill R,
Cristea M, Fleming GF, Tariq B, Fong A, French D, Rossi M, Brickman
D and Moore K: Tamrintamab pamozirine (SC-003) in patients with
platinum-resistant/refractory ovarian cancer: Findings of a phase 1
study. Gynecol Oncol. 158:640–645. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshitake H, Yanagida M, Maruyama M,
Takamori K, Hasegawa A and Araki Y: Molecular characterization and
expression of dipeptidase 3, a testis-specific membrane-bound
dipeptidase: Complex formation with TEX101, a germ-cell-specific
antigen in the mouse testis. J Reprod Immunol. 90:202–213. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schiza C, Korbakis D, Panteleli E, Jarvi
K, Drabovich AP and Diamandis EP: Discovery of a human
testis-specific protein complex TEX101-DPEP3 and selection of its
disrupting antibodies. Mol Cell Proteomics. 17:2480–2495. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hao JJ, Zhi X, Wang Y, Zhang Z, Hao Z, Ye
R, Tang Z, Qian F, Wang Q and Zhu J: Comprehensive proteomic
characterization of the human colorectal carcinoma reveals
signature proteins and perturbed pathways. Sci Rep. 7:424362017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu YF, Wang CY, Tang WC, Lee YC, Ta HDK,
Lin LC, Pan SR, Ni YC, Anuraga G and Lee KH: Expression profile and
prognostic value of Wnt signaling pathway molecules in colorectal
cancer. Biomedicines. 9:13312021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang G, Schetter A, He P, Funamizu N,
Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, et al:
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity
and predicts clinical outcome in pancreatic ductal adenocarcinoma.
PLoS One. 7:e315072012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cui X, Liu X, Han Q, Zhu J, Li J, Ren Z,
Liu L, Luo Y, Wang Z, Zhang D, et al: DPEP1 is a direct target of
miR-193a-5p and promotes hepatoblastoma progression by
PI3K/Akt/mTOR pathway. Cell Death Dis. 10:7012019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang W, Chen T, Liu J, Yu S, Liu L, Zheng
M, Liu Y, Zhang H, Bian T and Zhao X: RAB11FIP1: An indicator for
tumor immune microenvironment and prognosis of lung adenocarcinoma
from a comprehensive analysis of bioinformatics. Front Genet.
12:7571692021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamauchi M, Yamaguchi R, Nakata A, Kohno
T, Nagasaki M, Shimamura T, Imoto S, Saito A, Ueno K, Hatanaka Y,
et al: Epidermal growth factor receptor tyrosine kinase defines
critical prognostic genes of stage I lung adenocarcinoma. PLoS One.
7:e439232012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu G, Cheng Z, Huang Y, Zheng W, Yang S,
Lin C and Ye J: MyD88 mediates colorectal cancer cell
proliferation, migration and invasion via NF-κB/AP-1
signaling pathway. Int J Mol Med. 45:131–140. 2020.PubMed/NCBI
|
|
35
|
Wu DM, Zhang T, Liu YB, Deng SH, Han R,
Liu T, Li J and Xu Y: The PAX6-ZEB2 axis promotes metastasis and
cisplatin resistance in non-small cell lung cancer through PI3K/AKT
signaling. Cell Death Dis. 10:3492019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li F, Huang Q, Luster TA, Hu H, Zhang H,
Ng WL, Khodadadi-Jamayran A, Wang W, Chen T, Deng J, et al: In Vivo
Epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic
target in Kras-Mutant lung adenocarcinoma. Cancer Discov.
10:270–287. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song H, Liu D, Wang L, Liu K, Chen C, Wang
L, Ren Y, Ju B, Zhong F, Jiang X, et al: Methyltransferase like 7B
is a potential therapeutic target for reversing EGFR-TKIs
resistance in lung adenocarcinoma. Mol Cancer. 21:432022.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Si J, Ma Y, Lv C, Hong Y, Tan H and Yang
Y: HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma
patients by regulating the miR-146b-5p/IL-6/STAT3 axis. Mol Ther
Nucleic Acids. 26:613–624. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen J, Liu X, Xu Y, Zhang K, Huang J, Pan
B, Chen D, Cui S, Song H, Wang R, et al: TFAP2C-Activated MALAT1
modulates the chemoresistance of docetaxel-resistant lung
adenocarcinoma cells. Mol Ther Nucleic Acids. 14:567–582. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Choudhury SR, Babes L, Rahn JJ, Ahn BY,
Goring KR, King JC, Lau A, Petri B, Hao X, Chojnacki AK, et al:
Dipeptidase-1 is an adhesion receptor for neutrophil recruitment in
lungs and liver. Cell. 178:1205–1221.e17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lai W, Wang C, Lai R, Peng X and Luo J:
Lycium barbarum polysaccharide modulates gut microbiota to
alleviate rheumatoid arthritis in a rat model. NPJ Sci Food.
6:342022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song X, Du R, Gui H, Zhou M, Zhong W, Mao
C and Ma J: Identification of potential hub genes related to the
progression and prognosis of hepatocellular carcinoma through
integrated bioinformatics analysis. Oncol Rep. 43:133–146.
2020.PubMed/NCBI
|
|
44
|
Chen J, Xu D, Wang T, Yang Z, Yang Y, He K
and Zhao L: HMGB1 promotes the development of castration resistant
prostate cancer by regulating androgen receptor activation. Oncol
Rep. 48:1972022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yamanashi K, Menju T, Hamaji M, Tanaka S,
Yutaka Y, Yamada Y, Nakajima D, Ohsumi A, Aoyama A, Sato T, et al:
Prognostic factors related to postoperative survival in the newly
classified clinical T4 lung cancer. Eur J Cardiothorac Surg.
57:754–761. 2020.PubMed/NCBI
|
|
46
|
Toiyama Y, Inoue Y, Yasuda H, Saigusa S,
Yokoe T, Okugawa Y, Tanaka K, Miki C and Kusunoki M: DPEP1,
expressed in the early stages of colon carcinogenesis, affects
cancer cell invasiveness. J Gastroenterol. 46:153–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zeng C, Qi G, Shen Y, Li W, Zhu Q, Yang C,
Deng J, Lu W, Liu Q and Jin J: DPEP1 promotes drug resistance in
colon cancer cells by forming a positive feedback loop with ASCL2.
Cancer Med. 12:412–424. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xiong Y, Feng Y, Zhao J, Lei J, Qiao T,
Zhou Y, Lu Q, Jiang T, Jia L and Han Y: TFAP2A potentiates lung
adenocarcinoma metastasis by a novel miR-16
family/TFAP2A/PSG9/TGF-β signaling pathway. Cell Death Dis.
12:3522021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu X, Fu M, Xia D, Ji Z, Hu N, Leng Z,
Xie W, Fang Y and Zhang J: Overexpression of FAM83A is associated
with poor prognosis of lung adenocarcinoma. J Oncol.
2022:87673332022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kavanagh DP, Robinson J and Kalia N:
Mesenchymal stem cell priming: Fine-tuning adhesion and function.
Stem Cell Rev Rep. 10:587–599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
McCabe EM and Rasmussen TP: lncRNA
involvement in cancer stem cell function and epithelial-mesenchymal
transitions. Semin Cancer Biol. 75:38–48. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Leung EL, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hess DA, Wirthlin L, Craft TP, Herrbrich
PE, Hohm SA, Lahey R, Eades WC, Creer MH and Nolta JA: Selection
based on CD133 and high aldehyde dehydrogenase activity isolates
long-term reconstituting human hematopoietic stem cells. Blood.
107:2162–2169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Prasetyanti PR and Medema JP: Intra-tumor
heterogeneity from a cancer stem cell perspective. Mol Cancer.
16:412017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jiang P, Li F, Liu Z, Hao S, Gao J and Li
S: BTB and CNC homology 1 (Bach1) induces lung cancer stem cell
phenotypes by stimulating CD44 expression. Respir Res. 22:3202021.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Pan G, Liu Y, Shang L, Zhou F and Yang S:
EMT-associated microRNAs and their roles in cancer stemness and
drug resistance. Cancer Commun (Lond). 41:199–217. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Konoshenko M, Lansukhay Y, Krasilnikov S
and Laktionov P: MicroRNAs as predictors of lung-cancer resistance
and sensitivity to cisplatin. Int J Mol Sci. 23:75942022.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Danni X, Jiangzheng Z, Huamao S, Yinglian
P, Changcheng Y and Yanda L: Chaperonin containing TCP1 subunit 3
(CCT3) promotes cisplatin resistance of lung adenocarcinoma cells
through targeting the Janus kinase 2/signal transducers and
activators of transcription 3 (JAK2/STAT3) pathway. Bioengineered.
12:7335–7347. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang S, Cao M, Yan S, Liu Y, Fan W, Cui
Y, Tian F, Gu R, Cui Y, Zhan Y, et al: TRIM44 promotes BRCA1
functions in HR repair to induce Cisplatin Chemoresistance in Lung
Adenocarcinoma by Deubiquitinating FLNA. Int J Biol Sci.
18:2962–2979. 2022. View Article : Google Scholar : PubMed/NCBI
|
